![Carl Feldbaum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Feldbaum
Directeur/Membre du Conseil chez
Bio Ventures for Global Health
Profil
Carl B. Feldbaum was the founder of Palomar Corp.
(founded in 1993) and held the title of President from 1993 to 2005.
He is currently the Chairman of Bio Ventures for Global Health (since 2004) and the President of Biotechnology Innovation Organization (since 1993).
In his former positions, he served as Chairman of The Life Sciences Foundation, Director of Connetics Corp.
(2005-2006), Independent Director of Exelixis, Inc. (2007-2023), Non-Executive Director of Actelion Ltd. (2005-2015), Director of Cardiff Oncology, Inc. (2014-2015), and Director of The Biotechnology Institute.
Mr. Feldbaum received his undergraduate degree from Princeton University and his graduate degree from The University of Pennsylvania Law School.
Postes actifs de Carl Feldbaum
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | 01/01/2005 |
Bio Ventures for Global Health
 Bio Ventures for Global Health Bio Ventures for Global Health is an organization focused on leveraging biotechnology to address global health challenges. The non-profit company is based in Washington, DC. It collaborates with various stakeholders to develop innovative solutions for diseases that disproportionately affect low-resource settings. Through strategic partnerships and initiatives, the company aims to improve health outcomes and access to healthcare in underserved communities worldwide. The CEO of the company is James C. Greenwood. | Directeur/Membre du Conseil | 24/06/2013 |
Anciens postes connus de Carl Feldbaum
| Sociétés | Poste | Fin |
|---|---|---|
| EXELIXIS, INC. | Directeur/Membre du Conseil | 31/05/2023 |
| CARDIFF ONCOLOGY, INC. | Directeur/Membre du Conseil | 13/11/2015 |
| ACTELION | Directeur/Membre du Conseil | 08/05/2015 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Directeur/Membre du Conseil | 29/12/2006 |
Palomar Corp. | Fondateur | 01/01/2005 |
Formation de Carl Feldbaum
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bio Ventures for Global Health
Bio Ventures for Global Health Bio Ventures for Global Health is an organization focused on leveraging biotechnology to address global health challenges. The non-profit company is based in Washington, DC. It collaborates with various stakeholders to develop innovative solutions for diseases that disproportionately affect low-resource settings. Through strategic partnerships and initiatives, the company aims to improve health outcomes and access to healthcare in underserved communities worldwide. The CEO of the company is James C. Greenwood. | |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services Focuses on biotechnological research | Commercial Services |
Palomar Corp. | |
The University of Pennsylvania Law School
 The University of Pennsylvania Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Life Sciences Foundation
 The Life Sciences Foundation Miscellaneous Commercial ServicesCommercial Services Engages in education and biotechnology information dissemination | Commercial Services |
